How Biotech Companies Use Reactive Lymph Nodes as Baseline Immune Models
In modern drug discovery and translational research, understanding normal immune activation is just as critical as studying disease states. For biotech companies developing immunotherapies, vaccines, and immune-modulating drugs, selecting the right biological baseline can significantly influence experimental accuracy and regulatory confidence. One increasingly important reference material is the reactive lymph node, which serves as a … Read more